# STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19

> **NCT04817332** · PHASE3 · COMPLETED · sponsor: **University of Dundee** · enrollment: 406 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Brensocatib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04817332
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-05
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 406 (ACTUAL)
- **Last updated:** 2023-08-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04817332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04817332, "STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04817332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*